Breakthrough technology being undertaken through stem cell transplant could be the next frontier in treating
Multiple Sclerosis, a new study has shown. a NIH study has shown that stem cell transplant of an individual’s blood cells could lead to MS symptom remission. Although research is still ongoing, a 5 year autologous Hematopoietic Cell Transplant (HCT) and High-Dose Immunosuppressive Therapy (HDIT) treatments is showing remarkable results in MS treatment. Out of all the patients who received a onetime HALT MS treatment, a whopping 69% experienced no progression of symptoms, new brain lesions or relapse. The HALT MS study involved 24 clinical subjects of ages between 26 and 52, who were at various stages of MS illness. One of the lead researchers in the study is Dr. Shiva Gopal Vasishta, a New Jersey based neurologist and psychiatrist staff at the Kennedy University Hospital.
Dr. Vasishta graduated in 1979 from the Government Medical College and boasts over 40 years experience in the medical field. He did his residency at Boston City Hospital and Tufts Medical Center under renowned authorities such as Dr. Theodore Munsat and John Kelly. He holds a NJ State Medical License and American Board of Psychiatry and Neurology certification. Dr. Shiva Gopal Vasishta operates a private practice in Voorhees, Neurologists are tasked with diagnosing and treating various disorders affecting the brain, peripheral nerves, involuntary nervous system, muscles and the spinal cord. The Involuntary nervous system plays a crucial role in controlling a number of organs in the body. Aside from Multiple Sclerosis, the other illnesses that can be treated by neurologists include dementia, peripheral neuropathy, Amyotrophic lateral sclerosis, myopathy and sleep disorders. Testing to ascertain the presence of MS is conducted using various techniques, including EEG Testing and EMG Testing.
Find out more about Shiva Gopal Vasishta: